| Juha Jouhki, Chairman of the Board
Born: 1966
Education: M.Sc. (Tech.)
Board member since 2002, Chairman of the Board of Directors since 2005
Principal occupation: Managing Director, Biothom Oy
Principal employment history: Thominvest Oy and Thomproperties Oy, Partner 1999–2002, Managing Director 2002–2009. Contral Clinics Ltd., Managing Director 1996–1999. Contral Pharma Ltd., Co-founder, Chairman of the Board 1998–2002. Finncarriers Oy Ab, different positions 1992–1996.
Other simultaneous positions of trust:
Dreadnought Finance Oy, Thominvest Oy, Thomcapital Oy, Procarbon AB, Neomedit Oy, Alimetrics Oy, RAM Partners Oy, Chairman of the Board. Northern Antibiotics Oy, Member of the Board. Number of shares held in Biotie |
|
Pauli Marttila, Deputy Chairman of the Board
Born: 1958
Education: M.Sc. (Eng.)
Board member since March 2005
Principal occupation: Director, Business Development and Corporate Investments at Sitra, the Finnish Innovation Fund
Principal employment history: Sitra Ventures, Director 2006–2008, Sitra Life Sciences, Director 2005–2006. Sitra Life Sciences, Corporate Finance, Director 1999–2004. Neste Corp. (later Fortum Corp.), Management positions in several R&D operations and business operations since 1983, General Manager of New Developments business unit at Neste Chemicals in Finland 1996–1999. Neste Noptek Venture Capital Fund (Boston, USA), Manager 1993–1995. Finnish Consulate General (Los Angeles, USA), Assistant Attaché 1984–1985.
Other simultaneous positions of trust: BPM-Group Oy, Chairman of the Board of Directors. Mobidiag Oy, Chairman of the Board of Directors. Bio Fund I-III venture funds, Member of the Investment Committee. Next Wave Funds (New York, USA), Member of the Advisory Board.
Number of shares held in Biotie |
 | Riku Rautsola
Born: 1954
Education: Ph.D. (Econ.)
Board member since March 2004
Principal occupation: President and CEO, VIRxSYS Corporation, a leading genetherapy company
Principal employment history: Management, sales and research positions in Denmark, Germany, the United States and China over 20 years. Borean Pharma, President and CEO 2003–2004. Cosmix Molecular Biologicals, CEO since 2001. Boehringer Ingelheim, Beiersdorf and Fresenius, Management positions. Accelerating Access, a public and private initiative of the UN and the pharmaceutical industry, Founding Member and Chairman 2000–2001. ”Free Nevirapine for the Prevention of Mother to Child HIV Transmission”, Founder.
Other simultaneous positions of trust: VIRxSYS, Board member. Number of shares held in Biotie |
 | Piet Serrure
Born: 1954
Education: M.Sc. (Econ.)
Board member since March 2004
Principal occupation: Becap Bvba, Managing Director
Principal employment history: Benevent (venture capital company) 1985. Parnib (NIB Capital), Director and CEO until 2001. Origo Management, Managing Director 2001–2006. Managing Director Becap since 2006. 1976–1985 different positions at Du Pont de Nemours and Arthur Andersen. European Private Equity and Venture Capital Association (EVCA), Member of the Board of Directors until 2004.
Other simultaneous positions of trust: Europe Unlimited, Chairman of the Board of Directors. Member of the Board of Directors at Fin. Co, IPTE, Visys, Finalame, Wichard and Hybrigenics.
Number of shares held in Biotie |
 | Ann Hanham
Born: 1952
Education: Ph.D. from the University of British Columbia, MSc from Simon Fraser University, and a BSc from the University of Toronto. She was also Board Certified in Toxicology in 1986.
Board member since November 2008
Principal occupation: Managing Director and General Partner of Burrill & Company
Principal employment history: Prior to joining Burrill & Company, she was a co-founder and Vice President of Clinical & Regulatory Affairs at InterMune Pharmaceuticals, and prior to that, the Senior Director for Oncology Product Development at Otsuka Pharmaceuticals and the Medical Director for Celtrix Pharmaceuticals. She has also worked for Becton Dickinson in both regulatory and clinical affairs for the monoclonal antibody programme, and as a regulatory toxicologist with the Health Protection Branch of Health and Welfare Canada.
Other simultaneous positions of trust: A member of the Board of Directors of Adlyfe, Cardiokine (Observer), elbion NV, Endocyte, Logical Therapeutics, SCYNEXIS and Waterstone.
Number of shares held in Biotie
|
 | Bernd Kastler
Born: 1949
Education: Doctorate in law in 1980 from the University of Giessen (Germany).
Board member since: November 2008
Principal occupation: Company Director
Principal employment history: Dr. Bernd Kastler is the co-founder and present CEO of elbion NV. Prior to this, he was Member of the Executive Board of ASTA Medica AG, the pharmaceutical subsidiary of Degussa AG. His responsibilities included the finance and the human resources areas
Other simultaneous positions of trust:
Kastler GmbH, controlled company and Managing Director: beloni Konsortial Gesellschaft
Number of shares held in Biotie |
 | Christoph Schröder
Born: 1961
Education: Ph.D. in Finance from the Technische Universität in Berlin and graduated in Business Administration from Ludwig Maximilians-Universität in Munich.
Board member since: November 2008
Principal occupation: a General Partner for life sciences of TVMCapital
Principal employment history: Prior to this, he was a member of the BASF Pharma’s Executive Board (based in London) and was President of two corporate functions: Global Production/Supply Chain and Corporate Marketing. Following BASF Pharma’s acquisition by Abbott Laboratories in 2001, Dr. Schroder became a partner with JSB Partners, L.P., a specialized transatlantic investment banking and advisory firm in the life sciences industry, with offices in Berlin, Boston and Munich.
Other simultaneous positions of trust: Board seats on behalf of TVM Capital at Probiodrug AG (Halle, Germany) and Riemser AG (Greifswald/Leipzig, Germany).
Number of shares held in Biotie |
| Peter Fellner
Born: 1943
Education: Ph.D. in molecular biology
Board member since: October 2009
Principal occupation: Company Director
Principal employment history: CEO of Celltech Group Plc from 1990 to 2003, and its Chairman until 2004. CEO of Roche UK from 1986 to 1990, and also served as a Director of a number of other public companies
Other simultaneous position of trust: Chairman of Consort Medical Plc, Chairman of Vernalis Plc, Chairman of Astex Therapeutics Ltd, Director of UCB SA, Director of Evotec AG Number of shares held in Biotie
----
Updated November, 2009 |